BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 20817887)

  • 21. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent hit series hidden in high-throughput screening data.
    Varin T; Didiot MC; Parker CN; Schuffenhauer A
    J Med Chem; 2012 Feb; 55(3):1161-70. PubMed ID: 22185196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for identifying compounds that specifically target translation.
    Brandi L; Fabbretti A; Milon P; Carotti M; Pon CL; Gualerzi CO
    Methods Enzymol; 2007; 431():229-67. PubMed ID: 17923238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating the empirical null hypothesis into the Benjamini-Hochberg procedure.
    Ghosh D
    Stat Appl Genet Mol Biol; 2012 Jul; 11(4):. PubMed ID: 22850065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications.
    Dejaegher B; Heyden YV
    J Pharm Biomed Anal; 2011 Sep; 56(2):141-58. PubMed ID: 21632194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring growth rate in high-throughput growth phenotyping.
    Blomberg A
    Curr Opin Biotechnol; 2011 Feb; 22(1):94-102. PubMed ID: 21095113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Developability assessment with case studies highlighting the decision taking].
    Dumas J; Sévérac A; Lemoine C; Huille S; Rak A; Prades C
    Med Sci (Paris); 2019 Dec; 35(12):1171-1174. PubMed ID: 31903933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges and approaches to statistical design and inference in high-dimensional investigations.
    Gadbury GL; Garrett KA; Allison DB
    Methods Mol Biol; 2009; 553():181-206. PubMed ID: 19588106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.